These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8776014)

  • 21. Bone marrow transplantation beyond treatment of aplasia and neoplasia.
    Beutler E
    West J Med; 1994 Feb; 160(2):129-32. PubMed ID: 8160463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer and bone marrow transplantation with special reference to Gaucher's disease.
    Karlsson S; Correll PH; Xu L
    Bone Marrow Transplant; 1993; 11 Suppl 1():124-7. PubMed ID: 8448536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The status of hematopoietic stem cell transplantation in lysosomal storage disease.
    Malatack JJ; Consolini DM; Bayever E
    Pediatr Neurol; 2003 Nov; 29(5):391-403. PubMed ID: 14684234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells.
    Correll PH; Karlsson S
    Eur J Haematol; 1994 Nov; 53(5):253-64. PubMed ID: 7529197
    [No Abstract]   [Full Text] [Related]  

  • 30. Gaucher's disease: a review for the internist and hepatologist.
    Niederau C; Häussinger D
    Hepatogastroenterology; 2000; 47(34):984-97. PubMed ID: 11020862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of age.
    Frenkel EP
    Am J Med Sci; 1993 May; 305(5):331-44. PubMed ID: 8097903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells.
    Matzner U; Schestag F; Hartmann D; Lüllmann-Rauch R; D'Hooge R; De Deyn PP; Gieselmann V
    Hum Gene Ther; 2001 Jun; 12(9):1021-33. PubMed ID: 11399225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis.
    Grabowski GA
    Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathogenic mechanism and therapies for Gaucher's disease].
    Liu LY; Du SC; Zhang J; Ma D
    Yi Chuan; 2015 Jun; 37(6):510-6. PubMed ID: 26351046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaucher's disease: studies of gene transfer to haematopoietic cells.
    Barranger JA; Rice EO; Dunigan J; Sansieri C; Takiyama N; Beeler M; Lancia J; Lucot S; Scheirer-Fochler S; Mohney T; Swaney W; Bahnson A; Ball E
    Baillieres Clin Haematol; 1997 Dec; 10(4):765-78. PubMed ID: 9497863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease.
    Sawkar AR; D'Haeze W; Kelly JW
    Cell Mol Life Sci; 2006 May; 63(10):1179-92. PubMed ID: 16568247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell gene therapy for Niemann-Pick disease and other lysosomal storage diseases.
    Schuchman EH
    Chem Phys Lipids; 1999 Nov; 102(1-2):179-88. PubMed ID: 11001572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward gene therapy for Gaucher disease.
    Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
    Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.